300
Views
114
CrossRef citations to date
0
Altmetric
Original Article

Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus

, , , &
Pages 524-530 | Received 25 Sep 2007, Published online: 08 Jul 2009

References

  • Barrett NR. The lower esophagus lined by columnar epithelium. Surgery 1957; 41: 881–94
  • Adler RH. The lower esophagus lined by columnar epithelium: its association with hiatal hernia, ulcer, stricture and tumour. J Thorac Cardiovasc Surg 1963; 45: 13–32
  • Hawe A, Payne WS, Weiland LH. Adenocarcinoma in the columnar epithelial lined lower (Barrett) esophagus. Thorax 1973; 28: 511–4
  • Haggitt RC, Dean PJ, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70: 1–5
  • Sampliner RE, and the Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888–95.
  • Haggitt RC, Dean PJ. Adenocarcinoma in Barrett's epithelium. Barrett's esophagus: pathophysiology, diagnosis, and management, S Spechler, R Goyal. Elsevier, New York 1985; 153–66
  • Reid BJ, Weinstein WM. Barrett's esophagus and adenocarcinoma. Annu Rev Med 1987; 38: 477–92
  • Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000; 95: 1669–76
  • Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, Demeester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198: 554–65
  • Smith RRL, Hamilton SR, Boitnott JK, Rogers EL. The spectrum of carcinoma arising in Barrett's esophagus. A clinicopathologic study of 26 patients. Am J Surg Pathol 1984; 8: 563–73
  • Rosenberg JC, Budev H, Edwards RC, Singal S, Steiger Z, Sundareson AS. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 1985; 55: 1353–60
  • Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am J Surg Pathol 1995; 19: 183–91
  • Chalasani N, Wo JM, Waring JP. Racial differences in the histology, location and risk factors of esophageal cancer. J Clin Gastroenterol 1998; 26: 11–3
  • Rubio CA, Aberg A. Barrett's mucosa in conjunction with squamous carcinoma of the esophagus. Cancer 1991; 68: 583–6
  • Nilsson J, Skobe V, Johansson J, Willen R, Johnsson F. Screening for oesophageal adenocarcinoma: an evaluation of a surveillance program for columnar metaplasia of the oesophagus. Scand J Gastroenterol 2000; 35: 10–6
  • Csendes A, Burdiles P, Braghetto I, Smok G, Castro C, Korn O, et al. Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus. The need for long-term subjective and objective follow-up. Ann Surg 2002; 235: 178–85
  • Chaves P, Cardoso P, Mendes de Almeida JC, Dias Pereira A, Leitao CN, Soares J. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation. Hum Pathol 1999; 30: 1291–5
  • Qualman SJ, Murray RD, Juhling-McClung H, Lucas J. Intestinal metaplasia is age related in Barrett's oesophagus. Arch Path Lab Med 1990; 114: 1236–40
  • Dias Pereira A, Suspiro A, Chaves P, Saraiva A, Gloria L, Mendes de Almeida JC, et al. Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities?. Gut 1998; 42: 659–62
  • Oberg S, Johansson J, Wenner J, Johnsson F, Zilling T, Stael von Holstein CCS, et al. Endoscopic surveillance of columar-lined esophagus. Ann Surg 2001; 234: 619–26
  • Oberg S, Peters JH, Demeester TR, Lord RV, Johansson J, Demeester SR, et al. Determinants of intestinal metaplasia within the columnar-lined oesophagus. Arch Surg 2000; 135: 651–5
  • Csendes A, Smok G, Burdiles P, Korn O, Gradiz M, Rojas J, et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. Dis Esophagus 2003; 16: 24–8
  • Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997; 92: 407–13
  • Padda S, Ramirez FC. Accuracy in the diagnosis of short-segment Barrett's esophagus: the role of endoscopic experience. Gastrointest Endosc 2001; 54: 605–8
  • Kim SL, Waring JP, Spechler SJ, Sampliner RE, Doos WG, Krol WF, and The Department of Veterans Affairs Gastroesophageal Reflux Study Group, et al., Diagnostic inconsistencies in Barrett's esophagus. Gastroenterology 1994;107:945–9.
  • Eisen GM, Montgomery EA, Azumi N, Hartmann D-P, Bhargava P, Lippman M, et al. Qualitative mapping of Barrett's metaplasia: a prerequisite for intervention trials. Gastrointest Endosc 1999; 50: 814–8
  • Coad R, Shepherd NA. Barrett's oesophgus: definition, diagnosis and pathogenesis. Curr Diagn Pathol 2003; 9: 218–27
  • Shepherd NA. Barrett's esophagus: its pathology and neoplastic complications. Esophagus 2003; 1: 17–29
  • Watson A, Heading RC, Shepherd NA. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus: a Report of the Working Party of the British Society of Gastroenterology. BSG Guidelines Gastroenterol 2005;1–42.
  • Smith MA, Maxwell-Armstrong CA, Welch NT, Schofield JH. Surveillance for Barrett's oesophagus in the UK. Br J Surg 1999; 86: 276–80
  • Ramus JR, Gatenby PAC, Caygill CPJ, Watson A. Endoscopic surveillance intervals for columnar-lined oesophagus (CLO) and impact on detection of dysplastic disease. Can J Gastroenterol 2005; 19: R0090
  • Chandrasoma PT, Der R, Dalton P, Kobayash G, Ma Y, Peters J, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001; 25: 1188–93
  • Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000; 95: 3089–95
  • Falk GW, Chittajallu R, Goldblum JR, Biscotti CV, Geisinger KR, Petras RE, et al. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology 1997; 112: 2138–42
  • Hardwick RH, Morgan RJ, Warren BF, Lott M, Alderson D. Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. Dis Esophagus 1997; 10: 233–7
  • Alexander JA, Jones SM, Smith CJ, Doull JA, Gietzen TH, Rathgaber SW. Usefulness of cytopathology and histology in the evaluation of Barrett's esophagus in a community hospital. Gastrointest Endosc 1997; 46: 318–320
  • Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer 1992; 69: 8–16
  • Woolf GM, Riddell RH, Irvine EJ, Hunt RH. A study to examine agreement between endoscopy and histology for the diagnosis of columnar-lined (Barrett's) esophagus. Gastrointest Endosc 1989; 35: 541–4
  • Chobanian SJ, Cattau EL, Jr, Winters C, Johnson DA, Van Ness MM, Miremadi A, et al. In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. Gastrointest Endosc 1987; 33: 99–102
  • Stevens PD, Lightdale CJ, Green PHR, Siegel LM, Garcia-Carrasquillo RJ, Rotterdam H. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 1994; 40: 747–9
  • Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV. Methylene blue directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 1996; 44: 1–7
  • Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001; 54: 289–93
  • Sharma P, Weston AP, Topalovski M, Cherian R, Battacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003; 52: 24–7
  • Endo T, Awakawa T, Takahashi H, Arimura Y, Itoh F, Yamashita K, et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 2002; 55: 641–7
  • Ortner M-AEJ, Ebert B, Hein E, Zumbusch K, Nolte D, Sukowski U, et al. Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut 2003; 52: 28–33
  • Pfefer TJ, Paithankar DY, Poneros JM, Schomacker KT, Nishioka NS. Temporally and spectrally resolved fluorescence spectroscopy for the detection of high grade dysplasia in Barrett's esophagus. Lasers Surg Med 2003; 32: 10–16
  • Gerson LB, Triadafilopoulos G. Screening for esophageal adencarcinoma: an evidence-based approach. Am J Med 2002; 113: 499–505
  • van Sandick JW, van Lanschott JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43: 216–22
  • Fitzgerald RC, Saeed IT, Khoo D, Farthing MJG, Burnham WR. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci 2001; 46: 1892–8
  • Peters JH, Clark GWR, Ireland AP, Chandrasoma P, Smyrk TC, Demeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813–21
  • Fountoulakis A, Zafirellis KD, Dolan K, Dexter SPL, Martin IG, Sue-Ling HM. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 2004; 91: 997–1003
  • Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002; 122: 633–40
  • Ferguson MK, Durkin A. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 2002; 6: 29–36
  • Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L, et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 1997; 10: 190–5
  • Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, et al. Changing patterns and surgical results in adenocarcinoma of the oesophagus. Br J Surg 1997; 84: 119–25
  • Murphy SJ, Johnston BT, Murray LJ. British Society of Gastroenterology guidelines for the diagnosis of Barrett's oesophagus: are we casting the net too wide?. Gut 2006; 55: 1821–2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.